Breast: Page 72

Micrima raises over $5M in new financing round

By AuntMinnie.com staff writers

U.K.-based breast imaging technology developer Micrima said it has raised 3.8 million pounds ($5.2 million U.S.) in a new financing round.

March 29, 2021

FDA issues mammography alert for Tenn. facility

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) said it's alerting patients who received mammograms at Tennessee Women's Care in Nashville, TN, on or after November 1, 2019, that there may be possible problems with the quality of their mammograms.

March 29, 2021

Risk analysis could help triage women for mammography

By Emily Hayes

Prioritizing which women receive breast screening based on their risk factors could enable breast centers to focus on the patients who need screening most during backlogs such as what occurred during the COVID-19 pandemic according to a new study.

March 24, 2021

How to combat false negatives on breast MRI

By Will Morton

Breast MRI may be the most sensitive imaging modality available for detecting breast cancer, but it has its pitfalls: namely, a unique set of perceptual and cognitive errors that result in false negatives, according to an article published online March 19 in RadioGraphics.

March 22, 2021

Koios Medical's AI for detecting breast cancer gets CE Mark

By AuntMinnie.com staff writers

Koios Medical has received the CE Mark for its Koios DS Breast Smart Ultrasound decision-support software for interpreting breast ultrasound images.

March 17, 2021

FDA clears iCAD's ProFound AI for DBT

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared computer-aided detection (CAD) software developer iCAD's ProFound artificial intelligence (AI) version 3.0 for digital breast tomosynthesis (DBT).

March 15, 2021

Estrogen receptor tied to outcomes in DCIS

By AuntMinnie.com staff writers

The estrogen receptor plays a key role in predicting long-term outcomes in patients with ductal carcinoma in situ (DCIS), researchers from Queen Mary University of London reported in a study published online March 16 in Clinical Cancer Research.

March 15, 2021

ACR calls JAMA breast cancer article 'misleading'

By AuntMinnie.com staff writers

The American College of Radiology (ACR) is taking aim at an article and editorial published March 15 in JAMA Internal Medicine on recommendations for mammography screening found on the websites of breast imaging centers. The ACR said the articles are "misleading."

March 14, 2021

Study claims breast centers flout mammography screening guidelines

By Emily Hayes

A new study published March 15 in JAMA Internal Medicine claims that breast cancer centers are promoting mammography screening for women in their 40s, contrary to guidelines from the U.S. Preventive Services Task Force. Imaging experts are disputing the findings.

March 14, 2021

AI can triage DBT exams for priority review

By Will Morton

Artificial intelligence (AI) software may help reduce the workloads of breast imagers by helping them focus on the digital breast tomosynthesis (DBT) exams that are most likely to have cancer, according to research presented at ECR 2021.

March 11, 2021

Breast cancer data may fuel debate on screening women over 75

By Emily Hayes

Breast cancer is common in women over the age of 75 and many older women are getting screening mammograms, according to data published March 5 in Breast Cancer Research and Treatment. The data come as the U.S. Preventive Services Task Force is reviewing its breast screening guidelines.

March 11, 2021

Adenopathy may occur after COVID-19 vaccination

By Dr. Kristy Wolfel

As COVID-19 vaccinations become readily available, mammographers must be alert for the possibility that a recent COVID-19 vaccination may be responsible for patients with unilateral axillary adenopathy. Radiologist Dr. Kristy Wolfel explains what to look out for.

March 9, 2021

Previous Page

Page 72 of 573

Next Page